Last reviewed · How we verify
Lateral femoral cutaneous nerve block — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Lateral femoral cutaneous nerve block (Lateral femoral cutaneous nerve block) — Kafrelsheikh University.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Lateral femoral cutaneous nerve block TARGET | Lateral femoral cutaneous nerve block | Kafrelsheikh University | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Lateral femoral cutaneous nerve block CI watch — RSS
- Lateral femoral cutaneous nerve block CI watch — Atom
- Lateral femoral cutaneous nerve block CI watch — JSON
- Lateral femoral cutaneous nerve block alone — RSS
Cite this brief
Drug Landscape (2026). Lateral femoral cutaneous nerve block — Competitive Intelligence Brief. https://druglandscape.com/ci/lateral-femoral-cutaneous-nerve-block. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab